Tanaka, Urara; Kajioka, Shunichi; Finoti, Livia S.; Palioto, Daniela Bazan 
; Kinane, Denis F.; Benakanakere, Manjunatha R.
Source: Biomedicines. Unidade: FORP
Subjects: PERIODONTITE, INTERLEUCINA 10, METILAÇÃO DE DNA, FÁRMACOS, EXPRESSÃO GÊNICA, OSTEOCLASTO, ODONTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TANAKA, Urara et al. Decitabine inhibits bone resorption in periodontitis by upregulating anti-inflammatory cytokines and suppressing osteoclastogenesis. Biomedicines, v. 9, n. 2, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.3390/biomedicines9020199. Acesso em: 31 out. 2024.APA
Tanaka, U., Kajioka, S., Finoti, L. S., Palioto, D. B., Kinane, D. F., & Benakanakere, M. R. (2021). Decitabine inhibits bone resorption in periodontitis by upregulating anti-inflammatory cytokines and suppressing osteoclastogenesis. Biomedicines, 9( 2), 1-13. doi:10.3390/biomedicines9020199NLM
Tanaka U, Kajioka S, Finoti LS, Palioto DB, Kinane DF, Benakanakere MR. Decitabine inhibits bone resorption in periodontitis by upregulating anti-inflammatory cytokines and suppressing osteoclastogenesis [Internet]. Biomedicines. 2021 ; 9( 2): 1-13.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/biomedicines9020199Vancouver
Tanaka U, Kajioka S, Finoti LS, Palioto DB, Kinane DF, Benakanakere MR. Decitabine inhibits bone resorption in periodontitis by upregulating anti-inflammatory cytokines and suppressing osteoclastogenesis [Internet]. Biomedicines. 2021 ; 9( 2): 1-13.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/biomedicines9020199
